Gradient Investments LLC Novartis Ag Transaction History
Gradient Investments LLC
- $3.96 Billion
- Q1 2025
A detailed history of Gradient Investments LLC transactions in Novartis Ag stock. As of the latest transaction made, Gradient Investments LLC holds 5,376 shares of NVS stock, worth $599,316. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,376
Previous 5,285
1.72%
Holding current value
$599,316
Previous $514,000
16.54%
% of portfolio
0.02%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding NVS
# of Institutions
1,487Shares Held
131MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.36 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$912 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$766 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$622 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $240B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...